Zydus Lifesciences Gets CDSCO Panel Nod to Market Semaglutide Injection for Type 2 Diabetes

New Delhi: Drug major Zydus Lifesciences Limited has received a key regulatory clearance from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) for the…

Continue ReadingZydus Lifesciences Gets CDSCO Panel Nod to Market Semaglutide Injection for Type 2 Diabetes

Online Platform Offers India-Sourced Ozempic to US Consumers at Steep Discounts

Bengaluru: Online ⁠pharmacy platform SaveRxCanada.to said on Wednesday it has begun offering Novo Nordisk's blockbuster diabetes drug, Ozempic, sourced from India to U.S. patients, as demand for cheaper options grows.…

Continue ReadingOnline Platform Offers India-Sourced Ozempic to US Consumers at Steep Discounts

Implantoplasty fails to Reduce Fracture Resistance of Narrow Titanium Implants: Study

A new study published in the journal of Stomatologija showed that the fracture resistance of narrow-diameter titanium dental implants was not much reduced by implantoplasty. To handle restricted alveolar bone…

Continue ReadingImplantoplasty fails to Reduce Fracture Resistance of Narrow Titanium Implants: Study